Literature DB >> 24559320

Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.

Sharmila Masli1, Nader Sheibani, Claus Cursiefen, James Zieske.   

Abstract

Thrombospondins are a family of large multi-domain glycoproteins described as matricelluar proteins based on their ability to interact with a broad range of receptors, matrix molecules, growth factors or proteases, and to modulate array of cellular functions including intracellular signaling, proliferation and migration. Two members of the thrombospondin family, thrombospondin 1 (TSP-1) and thrombospondin 2 (TSP-2) are studied extensively to determine their structure and function. While expressed at low levels in normal adult tissues, their increased expression is seen predominantly in response to cellular perturbations. Despite structural similarities, a notable functional difference between TSP-1 and TSP-2 includes the ability of former to activate of latent TGF-β and its competitive inhibition by the latter. Both these thrombospondins are reported to play important roles in TGF-β rich ocular environment with most reports related to TSP-1. They are expressed by many ocular cell types and detectable in the aqueous and vitreous humor. TSP-1 and TSP-2 influence many cellular interactions in the eye such as angiogenesis, cell migration, wound healing, TGF-β activation and regulation of inflammatory immune responses. Together, these processes are known to contribute to the immune privilege status of the eye. Emerging roles of TSP-1 and TSP-2 in ocular functions and pathology are reviewed here.

Entities:  

Keywords:  Angiogenesis; immuneregulation; inflammation; lymphangiogenesis; wound healing

Mesh:

Substances:

Year:  2014        PMID: 24559320      PMCID: PMC4278647          DOI: 10.3109/02713683.2013.877936

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  109 in total

1.  Enhanced proangiogenic signaling in thrombospondin-1-deficient retinal endothelial cells.

Authors:  Yongji Wang; Shoujian Wang; Nader Sheibani
Journal:  Microvasc Res       Date:  2006-04-19       Impact factor: 3.514

2.  Impaired expression of thrombospondin-1 in eyes with age related macular degeneration.

Authors:  K Uno; I A Bhutto; D S McLeod; C Merges; G A Lutty
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

3.  The integrin alphaVbeta6 binds and activates latent TGFbeta3.

Authors:  Justin P Annes; Daniel B Rifkin; John S Munger
Journal:  FEBS Lett       Date:  2002-01-30       Impact factor: 4.124

4.  Thrombospondin-1 triggers cell migration and development of advanced prostate tumors.

Authors:  Virginie Firlej; Jacques R R Mathieu; Cristèle Gilbert; Loïc Lemonnier; Jessica Nakhlé; Catherine Gallou-Kabani; Basma Guarmit; Aurélie Morin; Natalia Prevarskaya; Nicolas Barry Delongchamps; Florence Cabon
Journal:  Cancer Res       Date:  2011-10-28       Impact factor: 12.701

5.  Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells.

Authors:  H Miyajima-Uchida; H Hayashi; R Beppu; M Kuroki; M Fukami; F Arakawa; Y Tomita; M Kuroki; K Oshima
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-02       Impact factor: 4.799

6.  Expression of thrombospondin in TGFbeta-treated APCs and its relevance to their immune deviation-promoting properties.

Authors:  Sharmila Masli; Bruce Turpie; Karl H Hecker; J Wayne Streilein
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

7.  Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-beta1 complex.

Authors:  Kelly L Walton; Yogeshwar Makanji; Justin Chen; Matthew C Wilce; Karen L Chan; David M Robertson; Craig A Harrison
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

8.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

9.  Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes.

Authors:  Shoujian Wang; Justin L Gottlieb; Christine M Sorenson; Nader Sheibani
Journal:  Arch Ophthalmol       Date:  2009-04

10.  CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.

Authors:  D W Dawson; S F Pearce; R Zhong; R L Silverstein; W A Frazier; N P Bouck
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

View more
  17 in total

1.  Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.

Authors:  Kelli A Lytle; Christopher M Depner; Carmen P Wong; Donald B Jump
Journal:  J Lipid Res       Date:  2015-08-27       Impact factor: 5.922

2.  Initiation of fibrosis in the integrin Αvβ6 knockout mice.

Authors:  Wenjing Wu; Audrey E K Hutcheon; Sriniwas Sriram; Jennifer A Tran; James D Zieske
Journal:  Exp Eye Res       Date:  2018-11-28       Impact factor: 3.467

Review 3.  Thrombospondin-1 in ocular surface health and disease.

Authors:  William Foulsham; Thomas H Dohlman; Sharad K Mittal; Yukako Taketani; Rohan Bir Singh; Sharmila Masli; Reza Dana
Journal:  Ocul Surf       Date:  2019-06-05       Impact factor: 5.033

Review 4.  Ovulation: Parallels With Inflammatory Processes.

Authors:  Diane M Duffy; CheMyong Ko; Misung Jo; Mats Brannstrom; Thomas E Curry
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

5.  Thrombospondin-1-Based Antiangiogenic Therapy.

Authors:  Jennifer N Sims; Jack Lawler
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-03       Impact factor: 2.671

6.  The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease.

Authors:  Xuhua Tan; Yihe Chen; William Foulsham; Afsaneh Amouzegar; Takenori Inomata; Yizhi Liu; Sunil K Chauhan; Reza Dana
Journal:  Ocul Surf       Date:  2018-07-25       Impact factor: 5.033

7.  Alteration in cellular turnover and progenitor cell population in lacrimal glands from thrombospondin 1-/- mice, a model of dry eye.

Authors:  Marie A Shatos; Robin R Hodges; Masahiro Morinaga; David E McNay; Rakibul Islam; Sumit Bhattacharya; Dayu Li; Bruce Turpie; Helen P Makarenkova; Sharmila Masli; Tor P Utheim; Darlene A Dartt
Journal:  Exp Eye Res       Date:  2016-09-30       Impact factor: 3.467

8.  Inflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival Cells.

Authors:  Laura Soriano-Romaní; Laura Contreras-Ruiz; Laura García-Posadas; Antonio López-García; Sharmila Masli; Yolanda Diebold
Journal:  J Ocul Pharmacol Ther       Date:  2015-07-08       Impact factor: 2.671

9.  Expression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells.

Authors:  Mitra Farnoodian; James B Kinter; Saeed Yadranji Aghdam; Ismail Zaitoun; Christine M Sorenson; Nader Sheibani
Journal:  Physiol Rep       Date:  2015-01-19

10.  Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes.

Authors:  Ingeborg Klaassen; Ewout W de Vries; Ilse M C Vogels; Antoine H C van Kampen; Machteld I Bosscha; David H W Steel; Cornelis J F Van Noorden; Sarit Y Lesnik-Oberstein; Reinier O Schlingemann
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.